journal article·2026-04

Mitochondrial‐Targeted Ultrasmall Hydrophobic Cationic Graphene Nanosheets Potentiating Tumor Photoimmunotherapy

Jiyuan Zhou, Mengnan Yang, Hengchuan Zhang, Tongyu Wu, Yuzhao Zheng, Xiaowen Huang, Jianping Zhou, Zhigui Su, Tingjie Yin

Advanced Functional Materials· Volume 36· Issue 29
Publisher page

Abstract

Abstract Mitochondria‐targeted drug delivery is a promising strategy to potentiate anti‐tumor efficacy. Current mitochondria‐targeting nano‐delivery strategies are mainly based on modification of lipophilic cation or targeting peptides. Due to endo/lysosomal capture and size limitation from mitochondrial outer membrane pores, neither approach guarantees efficient mitochondrial entry of the modified nanosystems. Herein, an ultrasmall hydrophobic cationic graphene oxide (GO‐ODA) based nanoplatform is developed for cascading of endo/lysosomal escape and precise inner mitochondrial membrane (IMM) targeting. The functional cascading originates from the strong Brownian motion and high edge density of the ultrasmall hydrophobic cationic GO‐ODA, which increases the frequency of edge‐induced scratching and lipid extraction against bio‐membranes during its random movement. Photosensitizers (PSs) with different charges are used as model therapeutics and loaded onto GO‐ODA surface, followed by co‐encapsulated within hyaluronic acid based amphiphile (IPHD) to form IPHD/GO‐ODA@PSs nanoparticles. The PSs loading dose‐optimized GO‐ODA@PSs are validated to feature membrane‐interactive properties for penetration, and prominently accumulate to IMM with inherent electronegativity. Upon laser irradiation, GO‐ODA@PSs induce severe mitochondrial dysfunction both in vitro and in vivo, and thus not only potentiate tumor inhibition, but also significantly enhance tumor immunogenicity through activating the cGAS‐STING pathway and GSDME‐mediated pyroptosis. It ultimately elicits a strong systemic antitumor immune response.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics China Pharmaceutical University 639 Longmian Avenue Nanjing 211198 China

Funding

National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1002/adma.20200777810.1002/adma.202007778 ↗
2. 10.3389/fbioe.2021.72050810.3389/fbioe.2021.720508 ↗
3. 10.3389/fbioe.2021.78460210.3389/fbioe.2021.784602 ↗
4. 10.1016/j.addr.2009.05.01010.1016/j.addr.2009.05.010 ↗
5. 10.1016/j.cbpa.2008.06.00210.1016/j.cbpa.2008.06.002 ↗
6. 10.1016/j.jconrel.2023.08.03210.1016/j.jconrel.2023.08.032 ↗
7. 10.1186/s12951‐019‐0562‐310.1186/s12951‐019‐0562‐3 ↗
8. 10.1021/acsnano.8b0321210.1021/acsnano.8b03212 ↗
9. 10.1016/j.biomaterials.2019.11929510.1016/j.biomaterials.2019.119295 ↗
10. 10.1021/acs.inorgchem.6b0002010.1021/acs.inorgchem.6b00020 ↗
11. 10.1021/acsami.8b2196810.1021/acsami.8b21968 ↗
12. 10.1021/acs.chemmater.9b0343010.1021/acs.chemmater.9b03430 ↗
13. 10.1038/s41551‐018‐0203‐410.1038/s41551‐018‐0203‐4 ↗
14. 10.1002/anie.20170482810.1002/anie.201704828 ↗
15. 10.1016/j.mtbio.2023.10056610.1016/j.mtbio.2023.100566 ↗
16. 10.1016/j.biomaterials.2022.12138310.1016/j.biomaterials.2022.121383 ↗
17. 10.1016/j.biomaterials.2024.12247210.1016/j.biomaterials.2024.122472 ↗
18. 10.1016/j.cell.2020.09.02010.1016/j.cell.2020.09.020 ↗
19. 10.1038/nature2405010.1038/nature24050 ↗
20. 10.1126/science.123245810.1126/science.1232458 ↗
21. 10.1002/advs.20220524110.1002/advs.202205241 ↗
22. 10.1016/j.apsb.2018.05.00610.1016/j.apsb.2018.05.006 ↗
23. 10.1002/cmdc.20190068610.1002/cmdc.201900686 ↗
24. 10.1021/jacs.7b1254510.1021/jacs.7b12545 ↗
25. 10.1002/anie.20191582610.1002/anie.201915826 ↗
26. 10.1016/j.biomaterials.2022.12153310.1016/j.biomaterials.2022.121533 ↗
27. 10.1021/bc500408p10.1021/bc500408p ↗
28. 10.1038/nmeth.269010.1038/nmeth.2690 ↗
29. 10.1016/j.jconrel.2015.10.02310.1016/j.jconrel.2015.10.023 ↗
30. 10.3390/molecules2311301610.3390/molecules23113016 ↗
31. 10.1016/j.jconrel.2022.08.01110.1016/j.jconrel.2022.08.011 ↗
32. 10.1016/j.addr.2023.11513110.1016/j.addr.2023.115131 ↗
33. 10.1021/acs.langmuir.9b0253610.1021/acs.langmuir.9b02536 ↗
34. 10.1038/nnano.2013.12510.1038/nnano.2013.125 ↗
35. 10.1098/rsfs.2017.006010.1098/rsfs.2017.0060 ↗
36. 10.1126/sciadv.aaw319210.1126/sciadv.aaw3192 ↗
37. 10.1016/j.biomaterials.2012.07.04010.1016/j.biomaterials.2012.07.040 ↗
38. 10.1073/pnas.122227611010.1073/pnas.1222276110 ↗
39. 10.1016/j.biomaterials.2020.12048110.1016/j.biomaterials.2020.120481 ↗
40. 10.1063/5.000460810.1063/5.0004608 ↗
41. 10.1002/jcc.2288510.1002/jcc.22885 ↗
42. 10.1016/j.csbj.2024.05.04910.1016/j.csbj.2024.05.049 ↗
43. 10.1002/jcc.2094510.1002/jcc.20945 ↗
44. 10.1021/acs.jpcb.3c0511210.1021/acs.jpcb.3c05112 ↗
45. 10.1063/1.44586910.1063/1.445869 ↗
46. 10.1002/jcc.2029110.1002/jcc.20291 ↗
47. 10.1016/0263‐7855(96)00018‐510.1016/0263‐7855(96)00018‐5 ↗
48. 10.1016/j.biomaterials.2024.12251210.1016/j.biomaterials.2024.122512 ↗
49. 10.1007/s12274‐008‐8021‐810.1007/s12274‐008‐8021‐8 ↗
50. 10.1021/ja01243a00810.1021/ja01243a008 ↗
51. 10.3390/jnt601000810.3390/jnt6010008 ↗
52. 10.1016/j.ejpb.2017.01.00210.1016/j.ejpb.2017.01.002 ↗
53. 10.1039/C9BM02010A10.1039/C9BM02010A ↗
54. 10.1016/j.actbio.2014.11.04110.1016/j.actbio.2014.11.041 ↗
55. 10.1002/adfm.20210447310.1002/adfm.202104473 ↗
56. 10.1016/j.biomaterials.2013.05.07110.1016/j.biomaterials.2013.05.071 ↗
57. 10.1002/adfm.20140001510.1002/adfm.201400015 ↗